Persistence to palbociclib treatment in HR+/HER2– breast cancer patients: A real-world study
Journal of Oncology Pharmacy Practice
Published online on January 14, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
ObjectiveTo evaluate adherence and persistence to palbociclib treatment in patients with advanced HR+/HER2– breast cancer in real-world clinical practice.MethodsThis observational, retrospective study was conducted using electronic medical records from ...
ObjectiveTo evaluate adherence and persistence to palbociclib treatment in patients with advanced HR+/HER2– breast cancer in real-world clinical practice.MethodsThis observational, retrospective study was conducted using electronic medical records from ...